Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 3, 1999

View Archived Issues

Antisoma Partners With Abbott For Cancer Product In Phase III

MHC Genome Aids Research Into Cause Of Many Diseases

Sugen Founder Criticizes UK Measures In Containing Costs

DrugAbuse Sciences Raises $22.4M In Private Financing

GenProfile Plans To Exploit Advances In Gene Analysis

Genomics Company Genfit Plans On Public Partnerships

Vanguard Medica Set Back As FDA Asks For More Data

EU Puts Off Decisions On Three Biotech Applications

Teva Offers Novopharm $700M For All Except Biotech Division

Cortecs Reduces R&D Focus As Part Of Change In Strategy

European Investment Bank Plans First Action In Biotech

NicOx Reduces Initial Offering After Doubt From U.S. Investors

Qiagen Among Companies Joining E-Commerce Alliance

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...